Fundz

Latigo Biotherapeutics Appoints Todd Smith as President and CEO

PUBLIC · LTGONov 05, 2026

Position

Chief Executive Officer

Company

Latigo Biotherapeutics

Nima Farzan
Thousand OaksBiotechnology

Description

On November 3, 2026, Latigo Biotherapeutics appointed Todd Smith as its President and Chief Executive Officer, succeeding Nima Farzan. Mr. Farzan will remain with the company through a transition period until January 1, 2027

Who to call at Latigo Biotherapeutics, and when

A new leader at Latigo Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Latigo Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Latigo Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Latigo Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Latigo Biotherapeutics

Location

Thousand Oaks, California, United States

About

Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Latigo Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Neil
Likely contact at this company
••••••••@••••••••

See Neil's verified email →

Sultan
Likely contact at this company
••••••••@••••••••

See Sultan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Latigo Biotherapeutics's next move

Learn about Strategic plan

Latigo Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.